BlueWhale Bio
Cell & Gene Therapy · Health Care
Funding and backers
Total raised
$5M
1 round on record
Latest round
$5M
Venture round · Oct 2025 · 12 mo ago
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2025 | $5M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | BlueWhale Bio, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Peter KellerExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Cellular Origins, ViaNautis
backs LEAH Labs
backs ViaNautis
backs ViaNautis
backs Celaid Therapeutics
Similar startupsby what they do, their industry and backers
セレイドセラピューティクス - 細胞治療(造血幹細胞). Change the futurewith cell therapy.
Supporting industry experts in cell therapy development and tumor detection. Discover our column-free cell isolation MARS platforms.
Advance your cell therapy with Cellipont Bioservices, a leading cell therapy CDMO, offering tailored development, analytics, and cGMP…
Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on…
Transforming disease treatment through cell and gene therapy. Join us at BlueRock to discover our cutting-edge science & clinical programs.
ViaNautis is transforming cell and gene therapy with polyNaut®, a versatile, non-viral, targeted polymer-based nanovesicles delivery system…
Visa sponsorship
0
H-1B filings in 12 months
0
Open roles in United States
In the register as BLUEWHALE BIO, INC., Philadelphia, PA
Other sponsors in the same field
Seek Labs 
Vyriad 
Krystal Biotech
Alert me
US Department of Labor · latest filing Nov 22, 2024 · Visa details by country
Financials
Total raised
$5M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $5M | Details |
People
Peter Keller
Executive Officer, Director
Paula Cannon
Director
Elaine Heron
Director
Paul Meister
Director
Beate Mueller-Tiemann
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Philadelphia
United States
HQ
Get in touch with us.We're here to assist you.
2929 Arch Street, Philadelphia, PA 19104